Clinical trial
Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
NCT00152620 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
- Lead sponsor
- University of Chicago
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2004
- Completion date
- May 31, 2007
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel disease (ibd)